Targeted Therapy Enhertu’s Cross Tumor Approval: Physician-Scientist Gerold Meinhardt From Drugmaker Daiichi Sankyo On The Huge Implications & The Next Round of HER2 Research

Updated April 30th, 2024

Targeted Therapy Enhertu’s Cross Tumor Approval: Physician-Scientist Gerold Meinhardt From Drugmaker Daiichi Sankyo On The Huge Implications & The Next Round of HER2 Research

NOW
PLAYING
Advances in Next Generation Sequencing and Immunotherapy for Endometrial Cancer: Tailored Treatments and Key Considerations
NOW
PLAYING
Immunotherapy Provides Hope for Women With Advanced Endometrial Cancer
NOW
PLAYING
Immunotherapy for Advanced Endometrial Cancer — What are the Side Effects?
NOW
PLAYING
How is Immunotherapy Used for Advanced or Recurrent Endometrial Cancer?
NOW
PLAYING
FDA Approves Durvalumab/Chemotherapy Combination for Hard-to-Treat Advanced Disease
NOW
PLAYING
Advanced or Recurrent Endometrial Cancer Patients Have New Hopeful Combination Therapy Option

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... breast cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider